1. Ubeda M, Rukstalis JM, Habener JF. Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity. J Biol Chem 2006; 281: 28858–28864.
2. Ridderstråle M, Groop L. Genetic dissection of type 2 diabetes. Mol Cell Endocrinol 2009; 297: 10–17.
3. Tabara Y, Osawa H, Kawamoto R et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 2009; 58: 493–498.
4. Wu Y, Li H, Loos RJ et al. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 2008; 57: 2834–2842.
5. Horikoshi M, Hara K, Ito C et al. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia 2007; 50: 2461–2466.
6. Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007; 39: 770–775.
7. Kirchhoff K, Machicao F, Haupt A et al. Polymorphisms in TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008; 51: 597–601.
8. Stančáková A, Kuulasmaa T, Paananen J et al. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5327 non-diabetic Finnish men. Diabetes 2009; 58: 2129–2136.
9. Unoki H, Takahashi A, Kawaguchi T et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 2008; 40: 1098–1102.
10. Ullrich S, Su J, Ranta F et al. Effects of I( Ks) channels inhibitors in insulin-secreting INS-1 cells. Pflugers Arch 2005; 451: 428–436.
11. Yasuda K, Miyake K, Horikawa Y et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008; 40: 1092–1097.
12. Lee Y, Kang ES, Kim SH et al. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet 2008; 53: 991–998.
13. Müssig K, Staiger H, Machicao F et al. Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion. Diabetes 2009; 58: 1715–1720.
14. Cauchi S, Meyre D, Dina C et al. Transcription factor TCF7L2 genetics study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006; 55: 2903–2908.
15. Lehman DM, Hunt KJ, Leach RJ et al. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes 2007; 56: 389–393.
16. Kimber CH, Doney AS, Pearson ER et al. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels. Diabetologia 2007; 50: 1186–1191.
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–1197.
18. Solé X, Guinó E, Valls J et al. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006; 22: 1928–1929.
19. Tong Y, Lin Y, Zhang Y et al. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 2009; 10: 15.